IL6 and delirium: Chronic low-grade inflammation, marked by elevated interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), disrupts neurotransmitter balance and impairs brain function, increasing delirium risk (Parrotta et al., 2023; Wilson et al., 2017).